Felocell^® 4

Vaccine

Felocell® 4 contains attenuated strains of feline herpesvirus type 1, calicivirus, panleukopenia virus (Johnson Snow Leopard strain), and Chlamydophila felis propagated on established cell lines, and lyophilised to preserve stability.

Felocell® 4 is intended for the vaccination of healthy cats and kittens as an aid in preventing feline rhinotracheitis (FVR) caused by feline herpesvirus-1, feline respiratory disease caused by feline calicivirus (FCV), feline panleukopenia (FPL) caused by feline panleukopenia virus and feline chlamydiosis caused by Chlamydophila felis.

Keep out of reach of children and uninformed persons.

• Vaccination of pregnant queens should be avoided.

• Post-vaccination reactions attributable to the vaccine may include lethargy, anorexia, ocular discharge and fever.

• If anaphylaxis or hypersensitivity occurs following use, administer adrenaline or equivalent. Without such treatment, serious reactions may result in death.

• This vaccine has been shown to be efficacious but some cats may be unable to develop or maintain an adequate immune response following vaccination if they are, for example, incubating any infectious disease, are malnourished or parasitised, or are stressed due to transport or adverse environmental conditions, or otherwise immunocompromised, or the vaccine is not administered according to label directions.

• Although this product has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

Prolonged exposure to higher temperatures may adversely affect potency.

Use entire contents when first opened.

Sterilised syringes and needles should be used to administer this vaccine. Do not sterilise with chemicals because traces of disinfectant may inactivate the vaccine.  

Admixing of the vaccine with any other may render it ineffective.

Burn containers and all unused contents.

Use only as directed. 

Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided.

General directions: Vaccination of healthy cats is recommended. Shake well. Aseptically administer 1 ml intramuscularly or subcutaneously.

Primary vaccination: Healthy cats 12 weeks of age or older should receive 2 doses, each administered 3 - 4 weeks apart. Cats vaccinated at less than 12 weeks of age should be revaccinated at 12 weeks of age.

Revaccination: Annual revaccination with a single dose is recommended.

Store between 2 °C and 7 °C. Do not freeze.

25 x 1 dose vials freeze dried vaccine and 25 vials sterile diluent.